EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study

Zhitong Yu, Tianyu Zhou, Yongduo Yu, Xuegui Tang, Shuxin Zhang, Lin Peng, Zhiming Ge, Zhongan Guan, Xiangan Zhang, Yuedong Liu, XiaoJun Sun, Yue Xu und 6 weitere

International Journal of Colorectal Disease · 26.02.2026 · 41 (1)

DOI: 10.1007/s00384-025-05057-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 26.02.2026. Verfasst von Zhitong Yu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning University of Traditional Chinese Medicine, Shenyang, China. Hauptthemen laut MEDLINE: Hemorrhoids, Polidocanol, Polyethylene Glycols, Sclerosing Solutions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To evaluate the effectiveness and safety of 3% polidocanol foam sclerotherapy (PFS) injection under anoscopy in the treatment of hemorrhoidal disease (HD) compared with rubber band ligation (RBL). METHOD: This was a multicenter, open-label, prospective, observational study that enrolled 222 patients with Goligher grade I, II, or III HD (internal or mixed), who were treated with 3% PFS or RBL, which depended on the physician's assessment and the patient's willingness. The primary endpoint was the clinical cure rate under anoscopy and clinical symptoms assessment at 4 weeks post-treatment. RESULTS: A total of 222 patients from 14 centers participated in the study, with 127 patients receiving PFS and 95 patients receiving RBL. Among the effectiveness analysis set (EAS), the clinical cure rate was 74.19% (69/93) in the PFS group and 83.13% (69/83) in the RBL group (P > 0.05). The PFS group showed quicker and better improvement in hemorrhage score post-treatment than the RBL group, with the mean (SD) changes from baseline in hemorrhage score of the two groups (P < 0.001) at 1, 4, and 12 weeks being -3.44 (1.99) vs. -1.70 (2.19), -3.85 (1.80) vs. -2.75 (2.02), and -3.81 (1.84) vs. -2.89 (2.10), respectively. The incidences of adverse events (AEs) were 2.36% (3/127) in the PFS group and 3.16% (3/95) in the RBL group, respectively, and no serious adverse events (SAEs) occurred in both groups. CONCLUSION: Patients treated with PFS showed similar effectiveness and safety as those treated with RBL under anoscopy, and a quick improvement trend in hemorrhage score post-treatment was observed in patients treated with PFS, but it needs further verification. TRIAL REGISTRATION: This study has been registered on the website of Chinese Clinical Trial Registry ( https://www.chictr.org.cn/ ), registration number: ChiCTR2200060325.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhoidsPolidocanolPolyethylene GlycolsSclerosing SolutionsSclerotherapyAdultAgedFemaleHumansMaleMiddle AgedProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Hemorrhage scoreInternal HDMixed HDPolidocanolRBL

Substanzen

PolidocanolPolyethylene GlycolsSclerosing Solutions

Autor:innen und Institutionen

  • Liaoning University of Traditional Chinese Medicine, Shenyang, China.
  • Department of Colorectal Medicine, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
  • The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 60, Huanghe North Avenue, Yuhong District, Shenyang, Liaoning, China. yuyongduo@163.com.
  • Integrative Chinese and Western Medicine Anorectal Department, Affiliated Hospital of North Sichuan Medical College, Sichuan, China.
  • Department of Anorectum, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, China.
  • Anorectal Department, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guang Dong, China.

Zitieren

APA

Yu, Z., Zhou, T., Yu, Y., Tang, X., Zhang, S., Peng, L., Ge, Z., Guan, Z., Zhang, X., Liu, Y., Sun, X., Xu, Y., Yang, W., Wang, R., Hu, X., Gao, J., Xin, S., & Li, X. (2026). Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study. International Journal of Colorectal Disease, 41(1). https://doi.org/10.1007/s00384-025-05057-8

Vancouver

Yu Z, Zhou T, Yu Y, Tang X, Zhang S, Peng L, et al. Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study. International Journal of Colorectal Disease. 2026;41(1). doi:10.1007/s00384-025-05057-8

BibTeX
@article{Yu2026,
  author = {Yu, Zhitong and Zhou, Tianyu and Yu, Yongduo and Tang, Xuegui and Zhang, Shuxin and Peng, Lin and Ge, Zhiming and Guan, Zhongan and Zhang, Xiangan and Liu, Yuedong and Sun, XiaoJun and Xu, Yue and Yang, Wei and Wang, Rong and Hu, Xiangdang and Gao, Jihua and Xin, Shiyong and Li, Xiaojian},
  title = {Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study},
  journal = {International Journal of Colorectal Disease},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1007/s00384-025-05057-8}
}
Kostenlos starten →